HomeTOP STORIESCorvus outlines January data readout for soquelitinib extension study as Phase II... Corvus outlines January data readout for soquelitinib extension study as Phase II atopic dermatitis trial set for Q1 2026 By rogerjudd November 5, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleDick Cheney’s Unwavering ImageNext articleCrude oil turns lower on stronger dollar, oversupply worries latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
